Delivery of a small-for-gestational-age infant and risk of maternal cardiovascular disease - a population-based record linkage study

Heart Lung and Circulation

Volumn 24, Issue 7, 2015, Pages 696-704

  Ngo, Anh D ^a   Roberts, Christine L ^a   Chen, Jian Sheng ^a   Figtree, Gemma ^a  

^a ROYAL NORTH SHORE HOSPITAL   (Australia)

Author keywords

Cardiovascular disease; Hospitalisation; International classification of disease; Record linkage; Small for gestational age

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; AUSTRALIA; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAUSE OF DEATH; CHILD; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DELIVERY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HEART FAILURE; HEART INFARCTION; HOSPITALIZATION; HUMAN; INCIDENCE; INFANT; LIVE BIRTH; MAJOR CLINICAL STUDY; MATERNAL AGE; MATERNAL DISEASE; MATERNAL HYPERTENSION; MATERNAL MORBIDITY; MATERNAL MORTALITY; MATERNAL WELFARE; ONSET AGE; PARITY; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SMALL FOR DATE INFANT; SMOKING; SOCIAL STATUS; YOUNG ADULT; FACTUAL DATABASE; MALE; NEWBORN; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR;

ADULT; AUSTRALIA; DATABASES, FACTUAL; FEMALE; HUMANS; INFANT, NEWBORN; INFANT, SMALL FOR GESTATIONAL AGE; LIVE BIRTH; MALE; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; RISK FACTORS;

EID: 84930869652     PISSN: 14439506     EISSN: 14442892     Source Type: Journal    
DOI: 10.1016/j.hlc.2015.01.004     Document Type: Article

References (45)

1. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012, 380(9859):2197-2223. Global Burdern of Disease Study Team.
2. Brown M.C., Best K.E., Pearce M.S., Waugh J., Robson S.C., Bell R. Cardiovascular disease risk in women with pre-eclampsia: systematic review and meta-analysis. European Journal of Epidemiology 2013, 28(1):1-19.
3. Oliver-Williams C.T., Heydon E.E., Smith G.C., Wood A.M. Miscarriage and future maternal cardiovascular disease: a systematic review and meta-analysis. Heart 2013, 99(22):1636-1644.
4. Robbins C.L., Hutchings Y., Dietz P.M., Kuklina E.V., Callaghan W.M. History of preterm birth and subsequent cardiovascular disease: a systematic review. American Journal of Obstetrics and Gynecology 2013.
5. Rich-Edwards J.W., Fraser A., Lawlor D.A., Catov J.M. Pregnancy characteristics and women's future cardiovascular health: An underused opportunity to improve women's health?. Epidemiologic Reviews 2014, 36(1):57-70.
6. Mosca L., Benjamin E.J., Berra K., Bezanson J.L., Dolor R.J., Lloyd-Jones D.M., et al. Effectiveness-based guidelines for the prevention of cardiovascular disease in women--2011 update: A guideline from the American Heart Association. Circulation 2011, 123(11):1243-1262.
7. Centers for Disease Control and Prevention. National Center for Health Statistics: Health Data Interactive. Secondary National Center for Health Statistics: Health Data Interactive 2012. http://www.cdc.gov/nchs/hdi.htm.
8. Peleg D., Kennedy C.M., Hunter S.K. Intrauterine growth restriction: identification and management. American Family Physician 1998, 58(2):453-460. 66-7.
9. Kanagalingam M.G., Nelson S.M., Freeman D.J., Ferrell W.R., Cherry L., Lowe G.D.O., et al. Vascular dysfunction and alteration of novel and classic cardiovascular risk factors in mothers of growth restricted offspring. Atherosclerosis 2009, 205(1):244-250.
10. Smith G.D., Sterne J., Tynelius P., Lawlor D.A., Rasmussen F. Birth weight of offspring and subsequent cardiovascular mortality of the parents. Epidemiology 2005, 16(4):563-569.
11. Wikstrom A.K., Haglund B., Olovsson M., Lindeberg S.N. The risk of maternal ischaemic heart disease after gestational hypertensive disease. BJOG 2005, 112(11):1486-1491.
12. Lykke J.A., Langhoff-Roos J., Lockwood C.J., Triche E.W., Paidas M.J. Mortality of mothers from cardiovascular and non-cardiovascular causes following pregnancy complications in first delivery. Paediatric and Perinatal Epidemiology 2010, 24(4):323-330.
13. Lykke J.A., Paidas M.J., Triche E.W., Langhoff-Roos J. Fetal growth and later maternal death, cardiovascular disease and diabetes. Acta Obstetricia et Gynecologica Scandinavica 2012, 91(4):503-510.
14. Bonamy A.K.E., Parikh N.I., Cnattingius S., Ludvigsson J.F., Ingelsson E. Birth characteristics and subsequent risks of maternal cardiovascular disease: Effects of gestational age and fetal growth. Circulation 2011, 124(25):2839-2846.
15. Pariente G., Sheiner E., Kessous R., Michael S., Shoham-Vardi I. Association between delivery of a small-for-gestational-age neonate and long-term maternal cardiovascular morbidity. International Journal of Gynecology and Obstetrics 2013, 123(1):68-71.
16. Bukowski R., Davis K.E., Wilson P.W.F. Delivery of a small for gestational age infant and greater maternal risk of ischemic heart disease. PLoS ONE 2012, 7(3).
17. Berghella V. Prevention of recurrent fetal growth restriction. Obstetrics and Gynecology 2007, 110(4):904-912.
18. Centre for Health Record Linkage. CHeReL Quality Assurance Procedures for Record Linkage. Secondary CHeReL Quality Assurance Procedures for Record Linkage. http://www.cherel.org.au/downloads.html.
19. Meray N., Reitsma J.B., Ravelli A.C., Bonsel G.J. Probabilistic record linkage is a valid and transparent tool to combine databases without a patient identification number. Journal of Clinical Epidemiology 2007, 60(9):883-891.
20. Dobbins T.A., Sullivan E.A., Roberts C.L., Simpson J.M. Australian national birthweight percentiles by sex and gestational age, 1998-2007. Medical Journal of Australia 2012, 197(5):291-294.
21. Kiyota Y., Schneeweiss S., Glynn R.J., Cannuscio C.C., Avorn J., Solomon D.H. Accuracy of Medicare claims-based diagnosis of acute myocardial infarction: estimating positive predictive value on the basis of review of hospital records. American Heart Journal 2004, 148(1):99-104.
22. Henderson T., Shepheard J., Sundararajan V. Quality of diagnosis and procedure coding in ICD-10 administrative data. Medical Care 2006, 44(11):1011-1019.
23. Roberts C.L., Bell J.C., Ford J.B., Morris J.M. Monitoring the quality of maternity care: how well are labour and delivery events reported in population health data?. Paediatric and Perinatal Epidemiology 2009, 23(2):144-152.
24. Roberts C.L., Bell J.C., Ford J.B., Hadfield R.M., Algert C.S., Morris J.M. The accuracy of reporting of the hypertensive disorders of pregnancy in population health data. Hypertension in Pregnancy 2008, 27(3):285-297.
25. Bell J.C., Ford J.B., Cameron C.A., Roberts C.L. The accuracy of population health data for monitoring trends and outcomes among women with diabetes in pregnancy. Diabetes Research and Clinical Practice 2008, 81(1):105-109.
26. Rushworth R.L., Bell S.M., Rob M.I., Taylor P.T. Diagnostic testing during pregnancy: a descriptive study of utilisation data. Australian Journal of Public Health 1994, 18:401-406.
27. Khambalia A.Z., Roberts C.L., Nguyen M., Algert C.S., Nicholl M.C., Morris J. Predicting date of birth and examining the best time to date a pregnancy. International Journal of Gynaecology and Obstetrics 2013, 123(2):105-109.
28. Pym M., Taylor L. Validation study of the NSW Midwives Data Collection 1990. NSW Public Health Bulletin 1993, 4:1-6.
29. Validation Study: NSW Midwives Data Collection 1998. New South Wales Mothers and Babies 2000, 9:97-99. NSW Health Department.
30. Ampt A.J., Ford J.B., Taylor L.K., Roberts C.L. Are pregnancy outcomes associated with risk factor reporting in routinely collected perinatal data?. NSW Public Health Bulletin 2013, 24:65-69.
31. Lykke J.A., Langhoff-Roos J., Sibai B.M., Funai E.F., Triche E.W., Paidas M.J. Hypertensive pregnancy disorders and subsequent cardiovascular morbidity and type 2 diabetes mellitus in the mother. Hypertension 2009, 53(6):944-951.
32. Catov J.M., Wu C.S., Olsen J., Sutton-Tyrrell K., Li J., Nohr E.A. Early or recurrent preterm birth and maternal cardiovascular disease risk. Annals of Epidemiology 2010, 20(8):604-609.
33. Catov J.M., Nohr E.A., Olsen J., Ness R.B. Chronic hypertension related to risk for preterm and term small for gestational age births. Obstetrics and Gynecology 2008, 112(2 Pt 1):290-296.
34. Davey Smith G., Hyppönen E., Power C., Lawlor D.A. Offspring birth weight and parental mortality: Prospective observational study and meta-analysis. American Journal of Epidemiology 2007, 166(2):160-169.
35. Kanagalingam M.G., Nelson S.M., Freeman D.J., Ferrell W.R., Cherry L., Lowe G.D., et al. Vascular dysfunction and alteration of novel and classic cardiovascular risk factors in mothers of growth restricted offspring. Atherosclerosis. 2009, 205(1):244-250.
36. Fraser A., Nelson S.M., Macdonald-Wallis C., Cherry L., Butler E., Sattar N., et al. Associations of pregnancy complications with calculated cardiovascular disease risk and cardiovascular risk factors in middle age: the Avon Longitudinal Study of Parents and Children. Circulation. 2012, 125(11):1367-1380.
37. Klebanoff M.A., Schulsinger C., Mednick B.R., Secher N.J. Preterm and small-for-gestational-age birth across generations. American Journal of Obstetrics and Gynecology 1997, 176(3):521-526.
38. Sattar N., Greer I.A. Pregnancy complications and maternal cardiovascular risk: opportunities for intervention and screeining?. BMJ 2002, 325:157-160.
39. Mehta S., Livingstone C., Borai A., Ferns G. Insulin-like Growth Factor Binding Protein-1 in Insulin Resistance and Cardiovascular Disease. British Journal of Diabetes and Vascular Disease 2012, 12(1):17-25.
40. Catov J.M., Newman A.B., Roberts J.M., Sutton-Tyrrell K.C., Kelsey S.F., Harris T., et al. Association Between Infant Birth Weight and Maternal Cardiovascular Risk Factors in the Health, Aging, and Body Composition Study. Annals of Epidemiology 2007, 17(1):36-43.
41. Luttun A., Tjwa M., Moons L., Wu Y., Angelillo-Scherrer A., Liao F., et al. Revascularization of ischemic tissues by PLGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1. Nature Medicine 2002, 8(8):831-840.
42. Berry J.D., Lloyd-Jones D.M., Garside D.B., Greenland P. Framingham risk score and prediction of coronary heart disease death in young men. American Heart Journal 2007, 154(1):80-86.
43. Michos E.D., Nasir K., Braunstein J.B., Rumberger J.A., Budoff M.J., Post W.S., et al. Framingham risk equation underestimates subclinical atherosclerosis risk in asymptomatic women. Atherosclerosis 2006, 184(1):201-206.
44. Grundy S.M., Bazzarre T., Cleeman J., D'Agostino R.B., Hill M., Houston-Miller N., et al. Prevention Conference V: Beyond secondary prevention: identifying the high-risk patient for primary prevention: medical office assessment: Writing Group I. Circulation 2000, 101(1):E3-E11.
45. Ridker P.M., Buring J.E., Rifai N., Cook N.R. Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score. JAMA: The Journal of the American Medical Association 2007, 297(6):611-619.